Iambic Therapeutics is listed on Rocketlist with 9 active roles. The company is categorized as AI Drug Discovery in BioTech. Iambic Therapeutics is at Series C stage, with a B2B business model, headquartered in San Diego, United States. Iambic Therapeutics was founded in 2019 and has 133 employees. Iambic Therapeutics has raised $306M. Active roles are refreshed daily from public hiring sources.